Laura Tadvalkar does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Cidara Therapeutics, Inc., and Hemab Therapeutics Holdings, Inc..

2024 was Laura Tadvalkar's most active year for acquiring shares with 2 total transactions. Laura Tadvalkar's most active month to acquire stocks was the month of March. 2024 saw Laura Tadvalkar paying a total of $0.00 for 6,375 shares, this is the most they've acquired in one year.